The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study

Overview of attention for article published in BMC Pediatrics, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source

twitter: 7 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 225 Mendeley

Summary Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 44,714 followers.

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study. https://t.co/nCHnIYP8hN #CBD #hemp #cannabidiol

27 Jul 2020

Reply Repost Favourite

難治性てんかん性脳症（CARE-E）研究の小児におけるＣＢＤ（カンナビジオール）のプロトコル：フェーズ1投与量増加研究。 https://t.co/CqFU0eL1B4 https://t.co/nCHnIYP8hN #ヘンプ論文 #てんかん

27 Jul 2020

Reply Repost Favourite

RT @yuji_masataka: エピディオレックス以外のCBD製剤を使った難治てんかんの治療報告が出始めている。 https://t.co/KgOBykcCa0

12 Jul 2018

Reply Repost Favourite

RT @yuji_masataka: エピディオレックス以外のCBD製剤を使った難治てんかんの治療報告が出始めている。 https://t.co/KgOBykcCa0

12 Jul 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.